Oragenics, Inc.
(NYSE Amex Equities : OGEN)

( )
OGEN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.73%158.710.0%$1286.08m
AMGNAmgen, Inc. 0.00%255.131.3%$694.68m
NVAXNovavax, Inc. 0.91%203.9380.0%$561.56m
SNSSSunesis Pharmaceuticals, Inc. 0.00%8.030.7%$561.33m
ILMNIllumina, Inc. 0.00%401.963.5%$517.94m
GILDGilead Sciences, Inc. 0.00%65.771.0%$463.29m
REGNRegeneron Pharmaceuticals, Inc. 0.00%494.642.7%$449.68m
VRTXVertex Pharmaceuticals, Inc. 0.00%221.101.9%$383.88m
ALXNAlexion Pharmaceuticals, Inc. 0.00%157.542.0%$298.86m
BNTXBioNTech SE -0.58%139.900.0%$264.82m
BIIBBiogen, Inc. 0.00%270.451.7%$264.46m
EXASEXACT Sciences Corp. 0.00%130.5218.4%$192.20m
NBIXNeurocrine Biosciences, Inc. 0.00%95.004.9%$177.73m
CRSPCRISPR Therapeutics AG 0.00%123.850.6%$174.50m
SGENSeagen Inc. 0.00%149.645.8%$153.69m

Company Profile

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.